» Authors » Jorge Rezende Filho

Jorge Rezende Filho

Explore the profile of Jorge Rezende Filho including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 90
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Braga A, Lopes R, Campos V, Freitas F, Maesta I, Sun S, et al.
Gynecol Oncol . 2023 Jul; 176:130-138. PMID: 37524011
Objective: To relate the distance traveled from the patient's residence to the gestational trophoblastic neoplasia (GTN) reference center (RC) and the occurrence of unfavorable clinical outcomes, as well as to...
2.
Braga A, Balthar E, Souza L, Samora M, Rech M, Madi J, et al.
Clinics (Sao Paulo) . 2023 Jul; 78:100260. PMID: 37523979
Objective: To evaluate the efficacy of immunotherapy for GTN treatment after methotrexate-resistance or in cases of multiresistant disease, through a systematic review, as well as to present the first 4...
3.
Braga A, Andrade T, Souza M, Campos V, Freitas F, Maesta I, et al.
Gynecol Oncol . 2023 Jan; 170:179-185. PMID: 36706644
Objective: To describe the natural history of hydatidiform mole (HM) after intracytoplasmic sperm injection (ICSI), emphasizing the clinical and oncological outcomes, as compared to patients who had HM after spontaneous...
4.
Braga A, Canelas A, Torres B, Maesta I, Pedrotti L, Bessel M, et al.
PLoS One . 2022 Dec; 17(12):e0277892. PMID: 36454778
Objective: To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among...
5.
Campos V, Paiva G, Padron L, Freitas F, Pedrotti L, Sun S, et al.
BJOG . 2022 Oct; 130(3):292-302. PMID: 36209485
Objective: To assess whether the incidence and aggressiveness of molar pregnancy (MP) and postmolar gestational trophoblastic neoplasia (GTN) changed during the COVID-19 pandemic. Design: Observational study with two separate designs:...
6.
Poli J, Paiva G, Freitas F, Mora P, Velarde L, Junior J, et al.
Gynecol Oncol . 2021 Jul; 162(3):638-644. PMID: 34266689
Objective: To compare the outcomes of patients with low-risk gestational trophoblastic neoplasia (GTN) treated with 8-day methotrexate (MTX) with two different regimens of folinic acid (FA). Methods: Retrospective cohort study...
7.
Braga A, Paiva G, Ghorani E, Freitas F, Velarde L, Kaur B, et al.
Lancet Oncol . 2021 Jun; 22(8):1188-1198. PMID: 34181884
Background: Patients with gestational trophoblastic neoplasia who have an International Federation of Gynaecology and Obstetrics (FIGO) risk score of 5 or 6 usually receive non-toxic single-agent chemotherapy as a first-line...
8.
Freitas F, Braga A, Viggiano M, Velarde L, Maesta I, Uberti E, et al.
Gynecol Oncol . 2020 May; 158(2):452-459. PMID: 32402634
Objective: To investigate GTN lethality among Brazilian women comparing cases of death by GTN with those who survived, thereby identifying factors associated with GTN lethality. Methods: We retrospectively reviewed medical...
9.
Braga A, de Souza Hartung Araujo C, Mora P, Paulino E, de Melo A, Velarde G, et al.
Gynecol Oncol . 2020 Jan; 156(3):598-605. PMID: 31928806
Objective: To compare the outcomes of patients with low-risk gestational trophoblastic neoplasia (GTN) treated with standard 8-day methotrexate/folinic acid (MTX/FA) versus modified regimen. Methods: Retrospective cohort study of patients with...
10.
Mora P, Sun S, Velarde G, Filho J, Uberti E, Esteves A, et al.
Gynecol Oncol . 2019 Mar; 153(2):277-285. PMID: 30857648
Objective: To evaluate the impact of periodic shortage of actinomycin-d (Act-d) in the treatment of Brazilian patients with low-risk gestational trophoblastic neoplasia (GTN) after methotrexate and folinic acid rescue (MTX/FA)...